| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | $1.24M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $499.66K | $302.16K | $567.19K | $3.56M | $8.54M |
| R&D | – | – | – | – | – |
| SG&A | $188.30K | $54.06K | $426.76K | $629.62K | $350.77K |
| Operating Income | -$499.66K | -$302.16K | -$567.19K | -$3.56M | -$7.29M |
| Interest Expense | $2.48M | $2.37M | $2.42M | $5.95M | $5.55M |
| Tax Expense | – | – | – | -$2.76M | -$3.00M |
| Net Income | -$2.98M | -$2.80M | -$5.30M | -$13.14M | -$14.26M |
| EPS (basic) | – | – | – | -0.0080 | -0.0400 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | $1.60B | $1.60B | $1.60B | $1.60B | – |